| 000 -LEADER |
|---|
| fixed length control field |
27603cam a22005774a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240322151847.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
co ugu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
060501t20072007moua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1416025529 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781416025528 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Language of cataloging |
eng |
| Transcribing agency |
KAMPALA UNIVERSITY NURSING SCHOOL |
| Modifying agency |
KAMPALA UNIVERSITY NURSING SCHOOL |
| Description conventions |
RDA |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM 301 |
| Item number |
.P457 2007 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 4 |
| Item number |
L 523 2007 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lehne, Richard A., |
| Dates associated with a name |
1943- |
| Relator term |
author |
| 9 (RLIN) |
3878 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmacology for nursing care / |
| Statement of responsibility, etc |
Richard A. Lehne, |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
6th ed |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Canada: |
| Name of publisher, distributor, etc |
Elsevier; |
| Date of publication, distribution, etc |
2007 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxii, 1,354 p. : |
| Other physical details |
col, ill ; |
| Dimensions |
29 cm + |
| Accompanying material |
1 CD-ROM (4 3/4 in.) |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 1. |
| Title |
Introduction -- |
| Miscellaneous information |
1. |
| Title |
Orientation to pharmacology -- |
| -- |
Four basic terms -- |
| -- |
Properties of an ideal drug -- |
| -- |
The therapeutic objective -- |
| -- |
Factors that determine the intensity of drug responses -- |
| Miscellaneous information |
2. |
| Title |
Application of pharmacology in nursing practice -- |
| -- |
Evolution of nursing responsibilities regarding drugs -- |
| -- |
Application of pharmacology in patient care -- |
| -- |
Application of pharmacology in patient education -- |
| -- |
Application of the nursing process in drug therapy -- |
| Miscellaneous information |
3. |
| Title |
Drug regulation, development, names, and information -- |
| -- |
Landmark drug legislation -- |
| -- |
New drug development -- |
| -- |
Drug names -- |
| -- |
Over-the-counter drugs -- |
| -- |
Sources of drug information -- |
| Miscellaneous information |
[pt]. 2. |
| Title |
Basic principles of pharmacology -- |
| Miscellaneous information |
4. |
| Title |
Pharmacokinetics -- |
| -- |
Application of pharmacokinetics in therapeutics -- |
| -- |
A note to chemophobes -- |
| -- |
Passage of drugs across membranes -- |
| -- |
Absorption -- |
| -- |
Distribution -- |
| -- |
Metabolism-- |
| -- |
Excretion -- |
| -- |
Time course of drug responses -- |
| Miscellaneous information |
5. |
| Title |
Pharmacodynamics -- |
| -- |
Dose-response relationships -- |
| -- |
Drug-receptor interactions -- |
| -- |
Drug responses that do not involve receptors -- |
| -- |
Interpatient variability in drug responses -- |
| -- |
The therapeutic index -- |
| Miscellaneous information |
6. |
| Title |
Drug interactions -- |
| -- |
Drug-drug interactions -- |
| -- |
Drug-food interactions -- |
| -- |
Drug-herb interactions |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
7. |
| Title |
Adverse drug reactions and medication errors -- |
| -- |
Adverse drug reactions -- |
| -- |
Medication errors -- |
| Miscellaneous information |
8. |
| Title |
Individual variation in drug responses -- |
| -- |
Body weight and composition -- |
| -- |
Age -- |
| -- |
Pathophysiology -- |
| -- |
Tolerance -- |
| -- |
Placebo effect -- |
| -- |
Variability in absorption -- |
| -- |
Genetics -- |
| -- |
Gender -- |
| -- |
Race -- |
| -- |
Failure to take medicine as prescribed -- |
| -- |
Drug interactions -- |
| -- |
Diet |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 3. |
| Title |
Drug therapy across the lifespan -- |
| Miscellaneous information |
9. |
| Title |
Drug therapy during pregnancy and breast-feeding -- |
| -- |
Drug therapy during pregnancy : basic considerations -- |
| -- |
Drug therapy during pregnancy : teratogenesis -- |
| -- |
Drug therapy during breast-feeding -- |
| Miscellaneous information |
10. |
| Title |
Drug therapy in pediatric patients -- |
| -- |
Pharmacokinetics : neonates and infants -- |
| -- |
Pharmacokinetics : children 1 year and older -- |
| -- |
Adverse drug reactions -- |
| -- |
Dosage determination -- |
| -- |
Promoting adherence -- |
| Miscellaneous information |
11. |
| Title |
Drug therapy in geriatric patients -- |
| -- |
Pharmacokinetic changes in the elderly -- |
| -- |
Pharmacodynamic changes in the elderly -- |
| -- |
Adverse drug reactions and drug interactions -- |
| -- |
Promoting adherence -- |
| Miscellaneous information |
[pt]. 4. |
| Title |
Peripheral nervous system drugs -- |
| -- |
Introduction -- |
| Miscellaneous information |
12. |
| Title |
Basic principles of neuropharmacology -- |
| -- |
How neurons regulate physiologic processes -- |
| -- |
Basic mechanisms by which neuropharmacologic agents act -- |
| Miscellaneous information |
13. |
| Title |
Physiology of the peripheral nervous system -- |
| -- |
Divisions of the nervous system -- |
| -- |
Overview of autonomic nervous system functions -- |
| -- |
Basic mechanisms by which the autonomic nervous system regulates physiologic processes -- |
| -- |
Anatomic considerations -- |
| -- |
Introduction to transmitters of the peripheral nervous system -- |
| -- |
Introduction to receptors of the peripheral nervous system -- |
| -- |
Exploring the concept of receptor subtypes -- |
| -- |
Locations of receptor subtypes -- |
| -- |
Functions of cholinergic and adrenergic receptor subtypes -- |
| -- |
receptor specificity of the adrenergic receptor subtypes -- |
| -- |
Receptor specificity of the adrenergic transmitters -- |
| -- |
Transmitter life cycles |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Title |
Cholinergic drugs -- |
| Miscellaneous information |
14. |
| Title |
Muscarinic agonists and antagonists -- |
| -- |
Muscarinic agonists -- |
| -- |
Muscarinic antagonists (anticholinergic drugs) -- |
| Miscellaneous information |
15. |
| Title |
Cholinesterase inhibitors and their use in myasthenia gravis -- |
| -- |
Reversible cholinesterase inhibitors -- |
| -- |
"Irreversible" cholinesterase inhibitors -- |
| -- |
Myasthenia gravis -- |
| Miscellaneous information |
16. |
| Title |
Drugs that block nicotinic cholinergic transmission : neuromuscular blocking agents and ganglionic blocking agents -- |
| -- |
Neuromuscular blocking agents -- |
| -- |
Ganglionic blocking agents -- |
| -- |
Adrenergic drugs -- |
| Miscellaneous information |
17. |
| Title |
Adrenergic agonists -- |
| -- |
Mechanisms of adrenergic receptor activation -- |
| -- |
Overview of the adrenergic agonists -- |
| -- |
Therapeutic applications and adverse effects of adrenergic receptor activation -- |
| -- |
Properties of representative adrenergic agonists -- |
| -- |
Discussion of adrenergic agonists in other chapters -- |
| Miscellaneous information |
18. |
| Title |
Adrenergic antagonists -- |
| -- |
Alpha-adrenergic antagonists 1 : therapeutic and adverse responses to alpha blockade -- |
| -- |
Alpha-adrenergic antagonists 2 : properties of individual alpha blockers -- |
| Miscellaneous information |
19. |
| Title |
Indirect-acting antiadrenergic agents -- |
| -- |
Adrenergic neuron-blocking agents -- |
| -- |
Centrally acting alpha₂ agonists |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 5. |
| Title |
Central nervous system drugs -- |
| Miscellaneous information |
20. |
| Title |
Introduction to central nervous system pharmacology -- |
| -- |
Transmitters of the CNS -- |
| -- |
The blood-brain barrier -- |
| -- |
How do CNS drugs produce therapeutic effects? -- |
| -- |
Adaptation of the CNS to prolonged drug exposure -- |
| -- |
Development of new psychotherapeutic drugs -- |
| -- |
Approaching the study of CNS drugs -- |
| -- |
Drugs for neurodegenerative disorders -- |
| Miscellaneous information |
21. |
| Title |
Drugs for Parkinson's disease -- |
| -- |
Pathophysiology of Parkinson's disease -- |
| -- |
Overview of drug therapy -- |
| -- |
Pharmacology of the drugs used for Parkinson's disease -- |
| Miscellaneous information |
22. |
| Title |
Alzheimer's disease -- |
| -- |
Pathophysiology of Alzheimer's disease -- |
| -- |
Risk factors, symptoms, and diagnosis -- |
| -- |
Drug therapy -- |
| Miscellaneous information |
23. |
| Title |
Drugs for multiple sclerosis -- |
| -- |
Overview of MS and its treatment -- |
| -- |
Disease modifying drugs 1 : immunomodulators -- |
| -- |
Disease modifying drugs 2 : immunosuppressants -- |
| -- |
Drugs used to manage MS symptoms -- |
| -- |
Neurologic drugs -- |
| Miscellaneous information |
24. |
| Title |
Drugs for epilepsy -- |
| -- |
Seizure generation-- |
| -- |
Types of seizures -- |
| -- |
How antiepileptic drugs work -- |
| -- |
Basic therapeutic considerations -- |
| -- |
Classification of antiepileptic drugs -- |
| -- |
Traditional antiepileptic drugs -- |
| -- |
Newer antiepileptic drugs -- |
| -- |
Management of epilepsy during pregnancy -- |
| -- |
Management of generalized convulsive status epilepticus |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
25. |
| Title |
Drugs for muscle spasm and spasticity -- |
| -- |
Seizure generation -- |
| -- |
Types of seizures -- |
| -- |
How antiepileptic drugs work -- |
| -- |
Basic therapeutic considerations-- |
| -- |
Classification of antiepileptic drugs -- |
| -- |
Traditional antiepileptic drugs -- |
| -- |
Newer antiepileptic drugs -- |
| -- |
Management of epilepsy during pregnancy -- |
| -- |
Management of generalized convulsive status epilepticus -- |
| -- |
Drugs for pain -- |
| -- |
Drug therapy of muscle spasm : centrally acting muscle relaxants -- |
| -- |
Drugs for spasticity -- |
| Miscellaneous information |
26. |
| Title |
Local anesthetics -- |
| -- |
Basic pharmacology of the local anesthetics -- |
| -- |
Properties of individual local anesthetics -- |
| -- |
Clinical use of local anesthetics -- |
| Miscellaneous information |
27. |
| Title |
General anesthetics -- |
| -- |
Basic pharmacology of the inhalation anesthetics -- |
| -- |
Properties of individual inhalation anesthetics -- |
| -- |
Intravenous anesthetics -- |
| Miscellaneous information |
28. |
| Title |
Opioid (narcotic) analgesics, opioid antagonists, and nonopioid centrally acting analgesics --Introduction to the opioids -- |
| -- |
Basic pharmacology of the opioids -- |
| -- |
Clinical use of opioids -- |
| -- |
Opioid antagonists -- |
| -- |
Nonopioid centrally acting analgesics -- |
| Miscellaneous information |
29. |
| Title |
Pain management in patients with cancer -- |
| -- |
Pathophysiology of pain -- |
| -- |
Management strategy -- |
| -- |
Assessment and ongoing evaluation -- |
| -- |
Drug therapy -- |
| -- |
Nondrug therapy -- |
| -- |
Pain management in special populations -- |
| -- |
patient education -- |
| -- |
JCAHO pain management standards |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
30. |
| Title |
Drugs for headache -- |
| -- |
Migraine headache 1 : characteristics and overview of treatment -- |
| -- |
Migraine headache 2 : abortive therapy -- |
| -- |
Migraine headache 3 : preventive therapy -- |
| -- |
Cluster headaches -- |
| -- |
Tension[type headache -- |
| -- |
Psychotherapeutic drugs -- |
| Miscellaneous information |
31. |
| Title |
Antipsychotic agents and their use in schizophrenia -- |
| -- |
Schizophrenia : clinical presentation and etiology-- |
| -- |
Conventional antipsychotic agents 1 : group properties -- |
| -- |
Conventional antipsychotic agents 2 : properties of individual agents -- |
| -- |
Atypical antipsychotic agents -- |
| -- |
Management of schizophrenia -- |
| Miscellaneous information |
32. |
| Title |
Antidepressants -- |
| -- |
Major depression : clinical features, pathogenesis, and treatment modalities -- |
| -- |
Suicide risk with antidepressant drugs -- |
| -- |
Tricyclic antidepressants -- |
| -- |
Selective serotonin reuptake inhibitors (SSRIs) -- |
| -- |
Serotonin/norepinephrine reuptake inhibitors (S/NRIs) -- |
| -- |
Monoamine oxidase inhibitors (MAOIs) -- |
| -- |
Atypical antidepressants -- |
| -- |
Electroconvulsive therapy -- |
| -- |
Vagus nerve stimulation -- |
| Miscellaneous information |
33. |
| Title |
Drugs for bipolar disorder -- |
| -- |
Characteristics of bipolar disorder -- |
| -- |
Treatment of bipolar disorder -- |
| -- |
Mood-stabilizing drugs -- |
| -- |
Antipsychotic drugs -- |
| Miscellaneous information |
34. |
| Title |
Sedative-hypnotic drugs -- |
| -- |
Benzodiazepines -- |
| -- |
Benzodiazepine-like drugs -- |
| -- |
Ramelteon : a melatonin agonist -- |
| -- |
Barbiturates -- |
| -- |
Miscellaneous sedative-hypnotics -- |
| -- |
Management of transient insomnia |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
35. |
| Title |
Management of anxiety disorders -- |
| -- |
Generalization anxiety disorder -- |
| -- |
Panic disorder -- |
| -- |
Obsessive-compulsive disorder -- |
| -- |
Social anxiety disorder (social phobia) -- |
| -- |
Post-traumatic stress disorder -- |
| Miscellaneous information |
36. |
| Title |
Central nervous system stimulants and attention-deficit/hyperactivity disorder -- |
| -- |
Amphetamines -- |
| -- |
Methylphenidate and dexmethylphenidate -- |
| -- |
Methylxanthines -- |
| -- |
Miscellaneous CNS stimulants -- |
| -- |
Attention-deficit/hyperactivity disorder -- |
| -- |
Drug abuse -- |
| Miscellaneous information |
37. |
| Title |
Drug abuse 1 : basic considerations -- |
| -- |
Definitions -- |
| -- |
Diagnostic criteria for substance abuse and substance dependence -- |
| -- |
Factors that contribute to drug abuse -- |
| -- |
neurobiology of addiction -- |
| -- |
Principles of addiction treatment -- |
| -- |
The Controlled Substance Act -- |
| Miscellaneous information |
38. |
| Title |
Drug abuse 2 : alcohol -- |
| -- |
Basic pharmacology of alcohol -- |
| -- |
Alcohol abuse -- |
| -- |
Drugs employed in alcohol abuse treatment -- |
| Miscellaneous information |
39. |
| Title |
Drug abuse 3 : major drugs of abuse (other than alcohol) -- |
| -- |
Heroin and other opioids -- |
| -- |
General CNS depressants -- |
| -- |
Psychostimulants -- |
| -- |
Marijuana and related preparations -- |
| -- |
Psychedelics -- |
| -- |
3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy) -- |
| -- |
Phencyclidine -- |
| -- |
Inhalants -- |
| -- |
Nicotine and smoking -- |
| -- |
Anabolic steroids |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 6. |
| Title |
Drugs that affect fluid and electrolyte balance -- |
| Miscellaneous information |
40. |
| Title |
Diuretics -- |
| -- |
Review of renal anatomy and physiology -- |
| -- |
Introduction to diuretics -- |
| -- |
High-ceiling (loop) diuretics -- |
| -- |
Thiazides and related diuretics -- |
| -- |
Thiazides and related diuretics -- |
| -- |
Potassium-sparing diuretics -- |
| -- |
Osmotic diuretics -- |
| Miscellaneous information |
41. |
| Title |
Agents affecting the volume and ion content of body fluids -- |
| -- |
Disorders of fluid volume and osmolality -- |
| -- |
Acid-base disturbances -- |
| -- |
Potassium imbalances -- |
| -- |
Magnesium imbalances -- |
| Miscellaneous information |
[pt]. 7. |
| Title |
Drugs that affect the heart, blood vessels, and blood -- |
| Miscellaneous information |
42. |
| Title |
Review of hemodynamics -- |
| -- |
Overview of the circulatory system -- |
| -- |
Regulation of cardiac output -- |
| -- |
Regulation of arterial pressure -- |
| Miscellaneous information |
43. |
| Title |
Drugs acting on the renin-angiotensin-aldosterone system -- |
| -- |
Physiology of the renin-angiotensin-aldosterone system -- |
| -- |
Angiotensin-converting enzyme inhibitors -- |
| -- |
Angiotensin 2 receptor blockers -- |
| -- |
Aldosterone antagonists -- |
| Miscellaneous information |
44. |
| Title |
Calcium channel blockers -- |
| -- |
Calcium channels : physiologic functions and consequences of blockade -- |
| -- |
Calcium channel blockers : classification and sites of action -- |
| -- |
Verapamil and diltiazem : agents that act on vascular smooth muscle and the heart -- |
| -- |
Dihydropyridines : agents that act mainly on vascular smooth muscle |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
45. |
| Title |
Vasodilators -- |
| -- |
Basic concepts invasodilator pharmacology -- |
| -- |
Pharmacology of individual vasodilators -- |
| Miscellaneous information |
46. |
| Title |
Drugs for hypertension -- |
| -- |
Classification of blood pressure -- |
| -- |
Types of hypertension -- |
| -- |
Consequences of hypertension -- |
| -- |
Management of chronic hypertension 1 : basic considerations -- |
| -- |
Management of chronic hypertension 2 : lifestyle modifications -- |
| -- |
Management of chronic hypertension 3 : drug therapy -- |
| -- |
Drugs for hypertensive emergencies -- |
| -- |
Drugs for hypertensive disorders of pregnancy -- |
| Miscellaneous information |
47. |
| Title |
Drugs for heart failure -- |
| -- |
Pathophysiology of heart failure -- |
| -- |
Overview of drugs used to treat heart failure -- |
| -- |
Cardiac (digitalis) glycosides -- |
| -- |
Management of heart failure -- |
| Miscellaneous information |
48. |
| Title |
Antidysrhythmic drugs -- |
| -- |
Electrical properties of the heart -- |
| -- |
Generation of dysrhythmias -- |
| -- |
Classification of antidysrhythmic drugs -- |
| -- |
Prodysrhythmic effects of antidysrhythmic drugs -- |
| -- |
Overview of common dysrhythmias and their treatment -- |
| -- |
Class 1 : sodium channel blockers -- |
| -- |
Class 2 : beta blockers -- |
| -- |
Class 3 : potassium channel blockers (drugs that delay repolarization) -- |
| -- |
Class 4 : calcium channel blockers -- |
| -- |
Other antidysrhythmic drugs -- |
| -- |
Principles of antidysrhythmic drug therapy -- |
| -- |
Nondrug treatment of dysrhythmias |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
49. |
| Title |
Prophylaxis of coronary heart disease : drugs that lower LDL cholesterol levels -- |
| -- |
Cholesterol -- |
| -- |
Plasma lipoproteins -- |
| -- |
Role of LDL cholesterol in atherosclerosis -- |
| -- |
Detection, evaluation, and treatment of high cholesterol : recommendations from ATP 3 -- |
| -- |
Drugs and other products used to alter plasma lipid levels -- |
| Miscellaneous information |
50. |
| Title |
Drugs for angina pectoris -- |
| -- |
Determinants of cardiac oxygen demand and oxygen supply -- |
| -- |
Angina pectoris : pathophysiology and treatment strategy -- |
| -- |
Organic nitrates -- |
| -- |
Beta blockers -- |
| -- |
Calcium channel blockers -- |
| -- |
Revascularization therapy : CABG and PCI -- |
| -- |
Summary of treatment measures -- |
| Miscellaneous information |
51. |
| Title |
Anticoagulant, antiplatelet, and thrombolytic drugs -- |
| -- |
Physiology and pathophysiology of coagulation -- |
| -- |
Overview of drugs used to treat thromboembolic disorders -- |
| -- |
Parenteral anticoagulants 1 : heparin and related drugs -- |
| -- |
Parenteral anticoagulants 2 : direct thrombin inhibitors -- |
| -- |
Warfarin, and oral anticoagulant -- |
| -- |
Antiplatelet drugs -- |
| -- |
Thrombolytic drugs -- |
| Miscellaneous information |
52. |
| Title |
Management of ST-elevation myocardial infarction -- |
| -- |
Pathophysiology of STEMI -- |
| -- |
Diagnosis of STEMI -- |
| -- |
Management of STEMI -- |
| -- |
Complications of STEMI -- |
| -- |
Secondary prevention of STEMI -- |
| Miscellaneous information |
53. |
| Title |
Drugs for hemophilia -- |
| -- |
Basic considerations -- |
| -- |
Preparations used to treat hemophilia -- |
| Miscellaneous information |
53. |
| Title |
Drugs for deficiency anemias -- |
| -- |
Red blood cell development -- |
| -- |
Iron deficiency -- |
| -- |
Vitamin B₁₂ deficiency -- |
| -- |
Folic acid defficiency -- |
| Miscellaneous information |
55. |
| Title |
Hematopoietic growth factors -- |
| -- |
Erythropoietic growth factors -- |
| -- |
Luekopoietic growth factors -- |
| -- |
Thrombopoietic growth factor |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 8. |
| Title |
Drugs for endocrine disorders -- |
| Miscellaneous information |
56. |
| Title |
Drugs for diabetes mellitus -- |
| -- |
Diabetes mellitus : overview of the disease and its treatment -- |
| -- |
Insulin 1 : physiology-- |
| -- |
Insulin 2 : preparations and administration -- |
| -- |
Insulin 3 : therapeutic use -- |
| -- |
Oral hypoglycemics for type 2 diabetes -- |
| -- |
New injectable drugs for diabetes -- |
| -- |
Diabetic ketoacidosis -- |
| -- |
Glucagon for insulin overdose -- |
| Miscellaneous information |
57. |
| Title |
Drugs for thyroid disorders -- |
| -- |
Thyroid physiology -- |
| -- |
Thyroid function tests -- |
| -- |
Thyroid pathophysiology -- |
| -- |
Thyroid hormone preparations for hypothyroidism -- |
| -- |
Drugs for hyperthyroidism -- |
| Miscellaneous information |
58. |
| Title |
Drugs related to hypothalamic and pituitary function -- |
| -- |
Overview of hypothalamic and pituitary endocrinology -- |
| -- |
Growth hormone -- |
| -- |
Prolactin -- |
| -- |
Thyrotropin -- |
| -- |
Corticotropin -- |
| -- |
Gonadotropins -- |
| -- |
Antidiuretic hormone -- |
| -- |
Oxytoxin -- |
| -- |
Drugs related to hypothalamic function -- |
| Miscellaneous information |
59. |
| Title |
Drugs for disorders of the adrenal cortex -- |
| -- |
Physiology of the adrenocortical hormones -- |
| -- |
Pathophysiology of the adrenocortical hormones -- |
| -- |
Agents for replacement therapy in adrenocortical insufficiency -- |
| -- |
Agents for diagnostic testing of adrenocortical function -- |
| -- |
Inhibitors of corticosteroid synthesis |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 9. |
| Title |
Women's health -- |
| Miscellaneous information |
60. |
| Title |
Estrogens and progestins : basic pharmacology and noncontraceptive applications -- |
| -- |
The menstrual cycle -- |
| -- |
Estrogens -- |
| -- |
Selective estrogen receptor modulators (SERMs) -- |
| -- |
Progestins -- |
| -- |
Menopausal hormone therapy -- |
| Miscellaneous information |
61. |
| Title |
Birth control -- |
| -- |
Effectiveness and safety of birth control methods -- |
| -- |
Selecting a birth control method -- |
| -- |
Oral contraceptives -- |
| -- |
Combination contraceptives with novel delivery systems -- |
| -- |
Long-acting contraceptives -- |
| -- |
Spermicides -- |
| -- |
Barrier devices -- |
| -- |
Drugs for medical abortion -- |
| Miscellaneous information |
62. |
| Title |
Drug therapy of infertility -- |
| -- |
Infertility : causes and treatment strategies -- |
| -- |
Drugs used to treat female infertility -- |
| Miscellaneous information |
63. |
| Title |
Drugs that affect uterine function -- |
| -- |
Uterine relaxants (tocolytics) and their use in preterm labor -- |
| -- |
Uterine stimulants (oxytocicis) -- |
| -- |
Drugs used to promote cervical ripening -- |
| Miscellaneous information |
[pt]. 10. |
| Title |
Men's health -- |
| Miscellaneous information |
64. |
| Title |
Androgens -- |
| -- |
Testosterone -- |
| -- |
Clinical pharmacology of the androgens -- |
| -- |
Androgen (anabolic steroid) abuse by athletes -- |
| Miscellaneous information |
65. |
| Title |
Drugs for erectile dysfunction and benign prostatic hyperplasia -- |
| -- |
Erectile dysfunction -- |
| -- |
Benign prostatic hyperplasia |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt.] 11. |
| Title |
Anti-inflammartory, antiallergic, and immunologic drugs -- |
| Miscellaneous information |
66. |
| Title |
Review of the immune system -- |
| -- |
Introduction to the immune system -- |
| -- |
Antibody-mediated (humoral) immunity -- |
| -- |
Cell-mediated immunity -- |
| Miscellaneous information |
67. |
| Title |
Childhood immunization -- |
| -- |
General considerations -- |
| -- |
Target diseases -- |
| -- |
Specific vaccines and toxoids -- |
| Miscellaneous information |
68. |
| Title |
Immunosuppressants -- |
| -- |
Calcineurin inhibitors -- |
| -- |
Sirlimus -- |
| -- |
Glucocorticoids -- |
| -- |
Cytotoxic drugs -- |
| -- |
Antibodies -- |
| Miscellaneous information |
69. |
| Title |
Antihistamines -- |
| -- |
Histamine -- |
| -- |
The two types of antihistamines : H₁ antagonists and H₂ antagonists -- |
| -- |
H₁ antagonists 1 : basic pharmacology -- |
| -- |
H₁ antagonists 2 : preparations -- |
| Miscellaneous information |
70. |
| Title |
Cyclooxygenase inhibitors : nonsteroidal anti-inflammatory drugs and acetaminophen -- |
| -- |
Mechanism of action -- |
| -- |
Classificationod cyclooxygenase inhibitors -- |
| -- |
First-generation NSAIDs -- |
| -- |
Second-generation NSAIDs (COX-2 inhibitors, coxibs) -- |
| -- |
Acetaminophen -- |
| Miscellaneous information |
71. |
| Title |
Glucocorticoids in nonendocrine diseases -- |
| -- |
Review of glucocorticoid physiology -- |
| -- |
Pharmacology of the glucocorticoids -- |
| Miscellaneous information |
[pt]. 12. |
| Title |
Drugs for bone and joint disorders -- |
| Miscellaneous information |
72. |
| Title |
Drug therapy of rheumatoid arthritis and gout -- |
| -- |
Drug therapy of rheumatoid arthritis -- |
| -- |
Drug therapy of gout -- |
| Miscellaneous information |
73. |
| Title |
Drugs affecting calcium levels and bone mineralization -- |
| -- |
Calcium physiology -- |
| -- |
Calcium-related pathophysiology-- |
| -- |
Drugs for disorders involving calcium -- |
| -- |
Osteoporosis |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 13. |
| Title |
Respiratory tract drugs -- |
| Miscellaneous information |
74. |
| Title |
Drugs for asthma -- |
| -- |
Pathophysiology of asthma -- |
| -- |
Overview of drugs for asthma -- |
| -- |
Administration of drugs by inhalation -- |
| -- |
Beta₂-adrenergic agonists -- |
| -- |
Glucocorticoids -- |
| -- |
Glucocorticoid/Beta₂ agonist combination -- |
| -- |
Cromolyn -- |
| -- |
Nedocromil -- |
| -- |
Methylxanthines -- |
| -- |
Anticholinergic drugs -- |
| -- |
Leukotriene modifiers -- |
| -- |
Omalizumab -- |
| -- |
Management of asthma -- |
| Miscellaneous information |
75. |
| Title |
Drugs for allergic rhinitis, cough, and colds -- |
| -- |
Drugs for allergic rhinitis -- |
| -- |
Drugs for cough -- |
| -- |
Cold remedies : combination preparations -- |
| Miscellaneous information |
[pt]. 14. |
| Title |
Gastrointestinal drugs -- |
| Miscellaneous information |
76. |
| Title |
Drugs for peptic ulcer disease -- |
| Miscellaneous information |
77. |
| Title |
Laxatives -- |
| Miscellaneous information |
78. |
| Title |
Other gastrointestinal drugs -- |
| -- |
Antiemetics -- |
| -- |
Drugs for motion sickness -- |
| -- |
Antidiarrheal agents -- |
| -- |
Drugs for irritable bowel syndrome -- |
| -- |
Drugs for inflammatory bowel disease -- |
| -- |
Prokinetic agents -- |
| -- |
Palifermin -- |
| -- |
Pancreatic enzymes -- |
| -- |
Drugs used to dissolve gallstones -- |
| -- |
Anorectal preparations -- |
| Miscellaneous information |
15. |
| Title |
Nutrition -- |
| Miscellaneous information |
79. |
| Title |
Vitamins -- |
| -- |
General considerations -- |
| -- |
Fat-soluble vitamins -- |
| -- |
Water-soluble vitamins -- |
| Miscellaneous information |
80. |
| Title |
Enteral and parenteral nutrition -- |
| -- |
Enteral nutritional therapy -- |
| -- |
Parenteral nutritional therapy -- |
| -- |
Drugs for obesity -- |
| -- |
Assessment of obesity-related health risk -- |
| -- |
Overview of obesity treatment -- |
| -- |
Weight-loss drugs approved for long-term use -- |
| -- |
Miscellaneous appetite suppressants -- |
| -- |
Investigational weight-loss drugs -- |
| -- |
Calorie-saving foods |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 16. |
| Title |
Chemotherapy of infectious diseases -- |
| Miscellaneous information |
82. |
| Title |
Basic principles of antimicrobial therapy -- |
| -- |
Selective toxicity -- |
| -- |
Classification of antimicrobial drugs -- |
| -- |
Acquired resistance to antimicrobial drugs -- |
| -- |
Selection of antibiotics -- |
| -- |
Host factors that modify drug choice, route of administration, or dosage -- |
| -- |
Dosage size and duration of treatment -- |
| -- |
Therapy with antibiotic combinations -- |
| -- |
Prophylactic use of antimicrobial drugs -- |
| -- |
Misuses of antimicrobial drugs -- |
| -- |
Monitoring antimicrobial therapy -- |
| Miscellaneous information |
83. |
| Title |
Drugs that weaken the bacterial cell wall 1 : penicillins -- |
| -- |
Introduction to the penicillins -- |
| -- |
Properties of individual penicillins -- |
| Miscellaneous information |
84. |
| Title |
Drugs that weaken the bacterial cell wall 2 : cephalosporins, carbapenems, vancomycin, aztreonam, teicoplanin, and fosfomycin -- |
| -- |
Cephalosporins -- |
| -- |
Carbapenems -- |
| -- |
Other inhibitors of cell wall synthesis -- |
| Miscellaneous information |
85. |
| Title |
Bacteriostatic inhibitors of protein synthesis : tetracyclines, macrolides and others -- |
| -- |
Tetracyclines -- |
| -- |
Macrolides -- |
| -- |
Other bacteriostatic inhibitors of protein synthesis -- |
| Miscellaneous information |
86. |
| Title |
Aminoglycosides : bactericidal inhibitors of protein synthesis -- |
| -- |
Basic pharmacology of the aminoglycosides -- |
| Miscellaneous information |
87. |
| Title |
Sulfonamides and trimethoprim -- |
| -- |
Sulfonamides -- |
| -- |
Trimethoprim -- |
| -- |
Trimethoprim/sulfamethoxazole -- |
| Miscellaneous information |
88. |
| Title |
Drug therapy of urinary tract infections -- |
| -- |
Organisms that cause urinary tract infections -- |
| -- |
Specific urinary tract infections and their treatment -- |
| -- |
Urinary tract antiseptics |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
89. |
| Title |
Antimycobacterial agents : drugs for tuberculosis, leprosy, and mycobacterium avium complex infection -- |
| -- |
Tuberculosis 1 : clinical considerations -- |
| -- |
Tuberculosis 2 : pharmacology of individual antituberculosis drugs -- |
| -- |
Drugs for leprosy (Hansen's disease) -- |
| -- |
Drugs for mycobacterium avium complex infection -- |
| Miscellaneous information |
90. |
| Title |
Miscellaneous antibacterial drugs : fluoroquinolones, metronidazole, daptomycin, rifampin, bacitracin, and polymyxins -- |
| -- |
Fluoroquinolones -- |
| -- |
Additional antibacterial drugs -- |
| Miscellaneous information |
91. |
| Title |
Antifungal agents -- |
| -- |
Drugs for systemic mycoses -- |
| -- |
Drugs for superficial mycoses -- |
| Miscellaneous information |
92. |
| Title |
Antiviral agents 1 : drugs for non-HIV viral infections -- |
| -- |
Drugs for infection with herpes simplex viruses and varicella-zoster virus -- |
| -- |
Drugs for cytomegalovirus infection -- |
| -- |
Drugs for hepatitis -- |
| -- |
Drugs for influenza -- |
| -- |
Drugs for respiratory syncytial virus infection -- |
| Miscellaneous information |
93. |
| Title |
Antiviral agents 2 : drugs for HIV infection and related opportunistic infections -- |
| -- |
Pathophysiology -- |
| -- |
Classification of antiretroviral drugs -- |
| -- |
Nucleoside/nucleotide reverse transcriptase inhibitors -- |
| -- |
Non-nucleoside reverse transcriptase inhibitors -- |
| -- |
Protease inhibitors -- |
| -- |
Enfuvirtide, an HIV fusion inhibitor -- |
| -- |
Management of HIV infection -- |
| -- |
Prophylaxis and treatment of opportunistic infections -- |
| -- |
HIV vaccines -- |
| -- |
Keeping current |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
94. |
| Title |
Drug therapy of sexually transmitted diseases -- |
| -- |
Chlamydia trachomatis infections -- |
| -- |
Gonococcal infections -- |
| -- |
Nongonococcal urethritis -- |
| -- |
Pelvic inflammatory disease -- |
| -- |
Acute epididymitis -- |
| -- |
Syphilis -- |
| -- |
Acquired immunodeficiency syndrome -- |
| -- |
Chancroid -- |
| -- |
Trichomoniasis -- |
| -- |
Bacterial vaginosis -- |
| -- |
Herpes simplex virus infections -- |
| -- |
Genital and anal warts (condylomata acuminata) -- |
| -- |
Proctitis -- |
| Miscellaneous information |
95. |
| Title |
Antiseptics and disinfectants -- |
| -- |
General considerations -- |
| -- |
Properties of individual antiseptics and disinfectants -- |
| -- |
Hand hygiene for healthcare workers -- |
| Miscellaneous information |
[pt]. 17. |
| Title |
Chemotherapy of parasitic diseases -- |
| Miscellaneous information |
96. |
| Title |
Anthelmintics -- |
| -- |
Classification of parasitic worms -- |
| -- |
Helminthic infestations -- |
| -- |
Drugs of choice for helminthiasis -- |
| Miscellaneous information |
97. |
| Title |
Antiprotozoal drugs 1: antimalarial agents -- |
| -- |
Life cycle of the malaria parasite -- |
| -- |
Types of malaria -- |
| -- |
Principles of antimalarial therapy -- |
| -- |
Pharmacology of the major antimalarial drugs -- |
| Miscellaneous information |
98. |
| Title |
Antiprotozoal drugs 2 : miscellaneous agents -- |
| -- |
Protozoal infections -- |
| -- |
Drugs of choice for protozoal infections -- |
| Miscellaneous information |
99. |
| Title |
Ectoparasiticides -- |
| -- |
Ectoparasitic infestations -- |
| -- |
Pharmacology of ectoparasiticides |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 18. |
| Title |
Cancer chemotherapy -- |
| Miscellaneous information |
100. |
| Title |
Basic principles of cancer chemotherapy -- |
| -- |
What is cancer? -- |
| -- |
The growth fraction and its relationship to chemotherapy -- |
| -- |
Obstacles to successful chemotherapy -- |
| -- |
Strategies for achieving maximum benefits from chemotherapy -- |
| -- |
Major toxicities of chemotherapeutic drugs -- |
| -- |
Making the decision to treat -- |
| -- |
Looking ahead -- |
| Miscellaneous information |
101. |
| Title |
Anticancer drugs 1: cytotoxic agents -- |
| -- |
Introduction to the cytotoxic anticancer drugs -- |
| -- |
Alkylating agents -- |
| -- |
Platinum compounds -- |
| -- |
Antimetabolites -- |
| -- |
Antitumor antibiotics -- |
| -- |
Mitotic inhibitors -- |
| -- |
Mitotic inhibitors -- |
| -- |
Topoisomerase inhibitors -- |
| -- |
Miscellaneous cytotoxic drugs -- |
| Miscellaneous information |
102. |
| Title |
Anticancer drugs 2 : hormonal agents, biologic response modifiers, and targeted drugs -- |
| -- |
Glucocorticoids -- |
| -- |
Drugs for prostate cancer -- |
| -- |
Drugs for breast cancer -- |
| -- |
Biologic response modifiers : immunostimulants -- |
| -- |
Targeted drugs -- |
| Miscellaneous information |
[pt]. 19. |
| Title |
Additional important drugs -- |
| Miscellaneous information |
103. |
| Title |
Drugs for the eye -- |
| -- |
Drugs for glaucoma -- |
| -- |
Cycloplegics and mydriatics -- |
| -- |
Drugs for allergic conjunctivitis -- |
| -- |
Drugs for age-related macular degeneration -- |
| -- |
Additional ophthalmic drugs |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
104. |
| Title |
Drugs for the skin -- |
| -- |
Anatomy of the skin -- |
| -- |
Topical glucocorticoids -- |
| -- |
Keratolytic agents -- |
| -- |
Acne -- |
| -- |
Sunscreens -- |
| -- |
Psoriasis -- |
| -- |
Other dermatologic drugs -- |
| Miscellaneous information |
105. |
| Title |
Drugs for the ear -- |
| -- |
Anatomy of the ear -- |
| -- |
Otitis media and its management -- |
| -- |
Otitis externa and its management -- |
| Miscellaneous information |
106. |
| Title |
Miscellaneous noteworthy drugs -- |
| -- |
Drugs for pulmonary arterial hypertension -- |
| -- |
Drotrecogin Alfa (activated) for severe sepsis -- |
| -- |
Drugs for neonatal respiratory distress syndrome -- |
| -- |
Drugs for cystic fibrosis -- |
| -- |
Drugs for sickle cell anemia -- |
| -- |
Drugs for hyperuicemia caused by cancer chemotherapy -- |
| -- |
Gamma-hydroxybutyrate for cataplexy in patients with narcolepsy -- |
| -- |
Riluzole for amyotrophic lateral sclerosis -- |
| Miscellaneous information |
[pt]. 20. |
| Title |
Alternative therapy -- |
| Miscellaneous information |
107. |
| Title |
Herbal supplements -- |
| -- |
Limited regulation : the Dietary Supplement Health and Education Act -- |
| -- |
Adverse interactions with conventional drugs -- |
| -- |
Oral formulations -- |
| -- |
Standardization of herbal products -- |
| -- |
Dosage -- |
| -- |
Some commonly used medicinal herbs |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
[pt]. 21. |
| Title |
Toxicology -- |
| Miscellaneous information |
108. |
| Title |
Management of poisoning -- |
| -- |
Fundamentals of treatment -- |
| -- |
Drugs and procedures used to minimize poison absorption -- |
| -- |
Drugs and procedures used for poison removal -- |
| -- |
Specific antidotes -- |
| -- |
Poison control centers -- |
| Miscellaneous information |
109. |
| Title |
Potential weapons of biologic, radiologic, and chemical terrorism -- |
| -- |
Bacteria and viruses -- |
| -- |
Biotoxins -- |
| -- |
Chemical weapons -- |
| -- |
Radiologic weapons -- |
| -- |
Appendixes -- |
| Miscellaneous information |
A. |
| Title |
Adult immunization -- |
| Miscellaneous information |
B. |
| Title |
Guide to gender-related drugs -- |
| Miscellaneous information |
C. |
| Title |
Pronunciation of generic drug names -- |
| Miscellaneous information |
D. |
| Title |
Weights and measures -- |
| Miscellaneous information |
E. |
| Title |
Normal laboratory values -- |
| Miscellaneous information |
F. |
| Title |
Commonly used abbreviations -- |
| Miscellaneous information |
G. |
| Title |
Techniques of drug administration -- |
| Miscellaneous information |
H. |
| Title |
Poison Control Centers in the United States -- |
| Miscellaneous information |
I. |
| Title |
Canadian drug information -- |
| Miscellaneous information |
J. |
| Title |
Major drug classes and their prototypes -- |
| Miscellaneous information |
K. |
| Title |
Very new drugs and important new formulations of older drugs |
| 538 ## - SYSTEM DETAILS NOTE |
|---|
| System details note |
System requirements for Windows: Windows 98se, 2000, or XP ; Pentium II 400 MHz or faster processor ; at least 64 MB RAM recommended ; 10 MB free hard disk space ; 48X or faster CD-ROM drive ; 800 x 600 monitor with True Color |
| 538 ## - SYSTEM DETAILS NOTE |
|---|
| System details note |
System requirements for Macintosh: OS X or greater ; Power Macintosh ; at least 64 MB RAM recommended ; 1 GHz+ PowerPC G4 ; 10 MB free hard disk space ; 48X or faster CD-ROM drive ; 800 x 600 monitor with Millions of colors |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| 9 (RLIN) |
3844 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nursing |
| 9 (RLIN) |
3976 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| 9 (RLIN) |
3844 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Therapy |
| 9 (RLIN) |
3869 |
| 655 #2 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Nurses' Instruction |
| 9 (RLIN) |
3887 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Books |
